The Effectiveness of a Health Promotion Program for Older People With Post-Covid-19 Sarcopenia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Post COVID-19 Condition
- Sponsor
- Mahidol University
- Enrollment
- 50
- Primary Endpoint
- Muscle strength
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The goal of this clinical trial is to investigate the prevalence of sarcopenia in older people with post-COVID-19 living in Ratchatewi district, Bangkok and to test the effectiveness of health promotion program for older people with post-COVID-19 Sarcopenia. The main questions it aim to answer are: • How many is the prevalence of sarcopenia in older people with post-COVID-19 living in Ratchatewi district, Bangkok? • Can the health promotion program improve muscle mass and muscle strength in older people with post-COVID-19 Sarcopenia ? Participants will be asked eating protein supplement one scoop /day and exercising 2 times/week for 3 months.
Investigators
Wanabhorn Tongchom
Principle investigator
Mahidol University
Eligibility Criteria
Inclusion Criteria
- •Older people with post-COVID-19 sarcopenia aged more than and equal 60 years
- •No disabilities
- •Able to read, write and communicate Thai langue
- •Live in Bangkok
- •Moderate post-covid-19 state defined by Thai version of the COVID-19 Yorkshire Rehabilitation Scale
- •No soy protein allergy
- •Sign inform consent
Exclusion Criteria
- •Severe post-covid-19 state defined by Thai version of the COVID-19 Yorkshire Rehabilitation Scale and complicated health problems
- •Disabilities
- •Unable to read, write and communicate Thai langue
- •Soy protein allergy
- •CKD 4 and CKD 5
- •Deny or withdraw from project
Outcomes
Primary Outcomes
Muscle strength
Time Frame: 3 motnhs
Muscle strength will be assessed using hand grip strength in kilograms.
Physical fitness
Time Frame: 3 months
Physical fitness will be measured using the Five Times Sit to Stand Test (FTSST) in second.
Muscle mass
Time Frame: 3 months
Muscle mass will be measured using BIA and calf circumference in kilograms.
Secondary Outcomes
- Prevalence of sarcopenia(3 months)